BBlogFlow

AI improving health care, but barriers remain: strategist - CTV News

·Oct 8, 2026

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

ADVERTISEMENTNorthern Ontario WatchIn this week's TechTalk segment, Tony Ryma and technology & change strategist Melissa Jakimik discuss AI in healthcare. Jakimik says AI is improving efficiency, predictive care and diagnostics, but fragmented data, privacy rules and safety standards are slowing wider adoption. October 08, 2026 at 5:28p.m. EDT

This article is an excerpt. To read the full content, visit the original source. CTV News

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

ASPI’s Critical Technology Tracker expands to include patent data - The Strategist | ASPI's analysis and commentary site

ASPI has expanded its globally recognised Critical Technology Tracker to include a new patent-analysis capability, introducing patent-based rankings across more than 20 of the 74 critical technologies tracked. Developed by ASPI’s Cyber, Technology and Security Program, the Critical Technology Tracker (CTT) maps global research performance across emerging technologies that are reshaping national security, economic resilience and global strategic advantage. Since its most recent update in June 2026, the CTT has shown that China leads in 69 of 74 tracked technologies – a signal of a structural shift in global technological power.

The Strategist | ASPI's analysis and commentary site·

Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Medical Xpress·

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·